Kanalas J J
Department of Pediatrics, University of Texas Health Science Center at San Antonio 78284-7813, USA.
Exp Cell Res. 1995 Jun;218(2):561-6. doi: 10.1006/excr.1995.1191.
Rat glomerular epithelial cells were grown to confluency on semipermeable tissue culture inserts and the plasminogen system of these cells was analyzed using enzyme assays, Western analysis, zymography, and reverse transcriptase-PCR. The glomerular epithelial cells are capable of activating exogenous plasminogen to plasmin by endogenous plasminogen activators. The cells produce both tissue-plasminogen activator and urokinase-plasminogen activator with urokinase being the prominent activator. Both activators are present primarily on the basolateral side of the cells with urokinase found primarily at the cell surface presumably bound to its receptor and tissue-plasminogen activator found primarily in the matrix secreted by the cells on the semipermeable insert. The cells also produce plasminogen activator inhibitor-1 and urokinase-plasminogen activator receptor. Inhibition of plasminogen activation occurred with plasminogen activator inhibitor-1, anti-catalytic anti-tissue-plasminogen activator antibody, epsilon-aminocaproic acid, which inhibits the binding of plasminogen through its lysine binding sites, and amiloride, which specifically inhibits urokinase.
将大鼠肾小球上皮细胞接种于半透性组织培养插入物上,使其生长至汇合状态,然后使用酶测定、蛋白质免疫印迹分析、酶谱分析和逆转录聚合酶链反应对这些细胞的纤溶酶原系统进行分析。肾小球上皮细胞能够通过内源性纤溶酶原激活剂将外源性纤溶酶原激活为纤溶酶。这些细胞同时产生组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂,其中尿激酶是主要的激活剂。两种激活剂主要存在于细胞的基底外侧,尿激酶主要位于细胞表面,推测与它的受体结合,而组织型纤溶酶原激活剂主要存在于半透性插入物上细胞分泌的基质中。这些细胞还产生纤溶酶原激活剂抑制剂-1和尿激酶型纤溶酶原激活剂受体。纤溶酶原激活抑制剂-1、抗催化抗组织型纤溶酶原激活剂抗体、ε-氨基己酸(通过其赖氨酸结合位点抑制纤溶酶原的结合)和氨氯吡咪(特异性抑制尿激酶)均可抑制纤溶酶原激活。